Home > Healthcare > Medical Devices > Diagnostic Devices > Rapid Diagnostics Market

Rapid Diagnostics Market Size

  • Report ID: GMI5745
  • Published Date: May 2023
  • Report Format: PDF

Rapid Diagnostics Market Size

Rapid Diagnostics Market size was over USD 37 billion in 2022 and will grow at a 7.6% CAGR between 2023 and 2032.

 

The increasing prevalence of infectious diseases will drive industry expansion. High prevalence of viral & microbial disease variants and the development of precise diagnostic tests will augment this growth. Hepatitis, influenza disease, dengue, and coronavirus are some of the most prevalent diseases globally. According to the World Health Organization (WHO), in 2021, around USD 354 million people globally were infected with Hepatitis and the rate is increasing at a steady pace. The high risk of infectious diseases will drive the adoption of rapid diagnostic testing. Furthermore, implementation of regulations and safety practices in healthcare settings will expand the customer base for medical gloves and other diagnostic equipment.

Low accuracy of results of rapid diagnostics may hinder market progress. Lack of proficiency to perform the test resulting in misdiagnosis may lead to serious damage. Inaccuracy in rapid diagnostic testing can lead to inappropriate treatment resulting in certain other complications. However, several market players are emphasizing on taking up innovative approaches to attain highly accurate rapid diagnostic testing in order to minimize the disadvantages associated with rapid diagnostic tests.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for rapid diagnostics was over USD 37 billion in 2022 and will grow at a 7.6% CAGR between 2023 and 2032.

Infectious disease testing segment will reach USD 20.9 billion by 2032 driven by rising prevalence of infectious disease and increasing need for the target disease diagnosis.

North America rapid diagnostics market size will reach USD 36.3 billion by 2032 fueled by the presence of key market players, and rising awareness regarding early-stage disease diagnosis.

Abbott, Roche, Quidel Corporation, Bio-Rad Laboratories, ACON Laboratories Inc., Danaher Corporation (HemoCue & Radiometer), and Alfa Scientific Designs Inc. among others.

Rapid Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 538
  • Countries covered: 30
  • Pages: 280
 Download Free Sample